Total Funding
87
65
Total FundingSeed raised
Growth Score 87 in past quarter
-2 pts
Heat Score 65 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
95255
FatiAbGen is a biopharmaceutical company that develops monoclonal antibody-based therapy for the treatment of infectious diseases.
- JayJay Lee: Co-Founder and CEOPast Role: SuperConnectr, Co-Founder
- Alexandre Joyeux: Chief Operation Officer
About the Company
FatiAbGen is a leading antibody-based platform company having a broad pre-clinical pipeline for Oncology and Allergy disease treatment using our own best-in-class therapeutic antibodies.